🇺🇸 FDA
Patent

US 10294215

Therapeutically active compounds and their methods of use

granted A61KA61K31/53A61K31/5377

Quick answer

US patent 10294215 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/53, A61K31/5377, A61P, A61P35/00